<--- Back to Details
First PageDocument Content
Cancer treatments / Oncology / Lung cancer / HMGB1 / DAMPs / Cancer vaccine / Squamous-cell carcinoma / Immunotherapy / Tumor antigen / Medicine / Immunology / Immune system
Date: 2013-06-20 09:56:23
Cancer treatments
Oncology
Lung cancer
HMGB1
DAMPs
Cancer vaccine
Squamous-cell carcinoma
Immunotherapy
Tumor antigen
Medicine
Immunology
Immune system

Microsoft PowerPoint - CDDIS[removed]T-f01

Add to Reading List

Source URL: www.nature.com

Download Document from Source Website

File Size: 570,67 KB

Share Document on Facebook

Similar Documents

Journal of Infection and Public Health, S31—S34 EGFR mutation testing in non-small cell lung cancer (NSCLC) Fouad Al Dayel 1 Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital an

DocID: 1vjEy - View Document

RESEARCH Efficacy, safety and economy of icotinib for advanced non-small cell lung cancer: a meta-analysis

DocID: 1vfqs - View Document

Warning: Smoking cigarettes contributes to lung disease, cancer, heart disease, stroke and respiratory illness and during pregnancy may result in low birth weight and premature birth.

DocID: 1v3MR - View Document

Signs and Symptoms of Lung Cancer Mohammed Zeitouni, MD, FCCP Consultant, Pulmonologist and Intensivist Department of Medicine King Faisal Specialist Hospital

DocID: 1v06s - View Document

Lung Cancer Academy Annual ConferenceOctober 2014, Al Faisal University CLASSIFICATION & MOLECULAR MARKERS OF LUNG ADENOCARCINOMA Fouad Al Dayel, MD, FRCPA, FRCPath

DocID: 1uZ8r - View Document